Primary Site >> Colorectal Cancer
Gene >> ULBP2
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity. PMID: 12884870 |
Ref: Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells. PMID: 19569244 |
Ref: ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients. PMID: 20054857 |
Ref: Methylation-specific ligation detection reaction (msLDR): a new approach for multiplex evaluation of methylation patterns. PMID: 21879293 |
Ref: The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma. PMID: 24242212 |
Ref: The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells. PMID: 24203492 Ref: Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia. PMID: 25393931 Ref: Metastatic colon cancer cell populations contain more cancer stem-like cells with a higher susceptibility to natural killer cell-mediated lysis compared with primary colon cancer cells. PMID: 25789015 |
Ref: Overexpression of the transcription factor ATF3 with a regulatory molecular signature associates with the pathogenic development of colorectal cancer. PMID: 28402947 Ref: A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer. PMID: 28607584 |
Ref: Independent prognostic genes and mechanism investigation for colon cancer. PMID: 29653552 |